Due Diligence

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

A mid pharma client, headquartered in Germany, wanted to have a level of confidence on their soon-to-be partner for manufacturing of their therapeutics.

Problem Statement:

A medium pharmaceutical client with capabilities in novel formulations was involved in a deal with a manufacturing company for commercial-scale manufacturing of the client’s therapies. The client involved DelveInsight to conduct a comprehensive appraisal of the partner’s business, prior to the closing of the deal between the two parties.

Our Methodology:
  • Manufacturing Capability Assessment through Site and Equipment Analysis
  • Financial Assessment through review of Quarterly and Annual Financial reports
  • Intellectual Property Assessment through Patent Assessment
  • Primary Analysis to establish references for the partner company’s credibility
Results:
  • Detailed Assessment Outcome of the capabilities and stability of the Partner Company
  • Analysis provided relating to the strength of the intellectual property of the Partner Company
  • References provided to support Due Diligence output
  • Analyst Comments on suitability of Partnership

Related Insights

Mergers and Acquisitions
Mergers and Acquisitions

A large medical device client, based in the United States with capabilities in drug delivery medical devices, [...]

View Case
Pipeline Assessment
Pipeline Assessment

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. [...]

View Case
Portfolio Management
Portfolio Management

A small-Pharma client based in Israel involved DelveInsight to manage their portfolio of candidates indicated for various infectious diseases. [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.